News & Updates
Filter by Specialty:
Show Multimedia Only
Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD
25 Nov 2025
byStephen Padilla
Treatment with semaglutide helps reduce kidney fat and enhance glomerular haemodynamic in adult patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), as shown in the REMODEL trial.
